Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia. | J Drugs Dermatol;22(6): 559-564, 2023 Jun 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL TCIM Americas

Traditional, Complementary and Integrative Medicine in the Americas VHL

Subject descriptor lookup Advanced Search

Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia.

Rapaport, Jeffrey; Sadgrove, Nicholas J; Arruda, Suleima; Swearingen, Alyssa; Abidi, Zehara; Sadick, Neil.

J Drugs Dermatol ; 22(6): 559-564, 2023 Jun 01.

Article in En | MEDLINE | ID: mdl-37276165

Subject(s)

Alopecia; Finasteride; Male; Female; Humans; Treatment Outcome; Alopecia/therapy; Minoxidil; Drug Administration Schedule

Search on Google

Full text: 1 Database: MEDLINE Main subject: Finasteride / Alopecia Language: En Journal: J Drugs Dermatol Year: 2023 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Finasteride / Alopecia Language: En Journal: J Drugs Dermatol Year: 2023 Type: Article